Tuberculosis Trial, Recruiting NCT06963606 Sponsor: Xuelin Yang Condition: Tuberculosis
Back to Tuberculosis

Tuberculosis Trial, Recruiting

NCT06963606
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who receive medical care at a primary healthcare hospital in Yichang City, Hubei Province, China, and have had a chest X-ray taken there
  • People who are older than 15 years of age
  • People who have respiratory symptoms or signs that may be related to tuberculosis
  • People who have not previously been diagnosed with active pulmonary (lung) tuberculosis
  • People who are able to complete laboratory tests to look for the presence of infection, as well as any follow-up tests required by the study

Who may not be able to join:

  • People who are diagnosed with a form of tuberculosis that affects parts of the body other than the lungs, or with a hidden (inactive) tuberculosis infection, at the time of their current visit
  • People whose chest X-ray images are not clear enough or do not meet the quality standards required for the study
  • People whose identity information cannot be confirmed or is not recognised in the system
  • People who are unable to complete the required follow-up period during the study
  • People who experience a sudden serious illness during the study, or who choose to stop participating

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Wang Ye Prof, chool of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing

Phone: 0536-13964768397

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Xuelin Yang
Registry
ClinicalTrials.gov
Start date
1 September 2025
Est. completion
31 December 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

The difference in the diagnostic yield of pulmonary tuberculosis screening in township medical and health institutions between the intervention group and the control group.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov